nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.527	1	CbGbCtD
Rifabutin—HSP90AA1—pons—amyotrophic lateral sclerosis	0.0293	0.209	CbGeAlD
Rifabutin—HSP90B1—hindbrain—amyotrophic lateral sclerosis	0.0156	0.111	CbGeAlD
Rifabutin—HSP90AA1—hindbrain—amyotrophic lateral sclerosis	0.0114	0.0812	CbGeAlD
Rifabutin—HSP90AA1—HSF1 activation—VCP—amyotrophic lateral sclerosis	0.0111	0.0599	CbGpPWpGaD
Rifabutin—Pseudomembranous colitis—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0728	CcSEcCtD
Rifabutin—White blood cell count decreased—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0728	CcSEcCtD
Rifabutin—Lymphopenia—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0708	CcSEcCtD
Rifabutin—HSP90B1—Unfolded Protein Response (UPR)—YIF1A—amyotrophic lateral sclerosis	0.00985	0.0532	CbGpPWpGaD
Rifabutin—HSP90B1—embryo—amyotrophic lateral sclerosis	0.00974	0.0694	CbGeAlD
Rifabutin—Platelet count decreased—Riluzole—amyotrophic lateral sclerosis	0.00899	0.0609	CcSEcCtD
Rifabutin—HSP90B1—brainstem—amyotrophic lateral sclerosis	0.00892	0.0636	CbGeAlD
Rifabutin—HSP90B1—Unfolded Protein Response (UPR)—EXOSC9—amyotrophic lateral sclerosis	0.00811	0.0438	CbGpPWpGaD
Rifabutin—HSP90AA1—embryo—amyotrophic lateral sclerosis	0.00712	0.0508	CbGeAlD
Rifabutin—HSP90B1—Scavenging by Class A Receptors—APOE—amyotrophic lateral sclerosis	0.00679	0.0367	CbGpPWpGaD
Rifabutin—HSP90AA1—brainstem—amyotrophic lateral sclerosis	0.00653	0.0465	CbGeAlD
Rifabutin—HSP90B1—medulla oblongata—amyotrophic lateral sclerosis	0.00622	0.0444	CbGeAlD
Rifabutin—HSP90B1—Unfolded Protein Response (UPR)—DCTN1—amyotrophic lateral sclerosis	0.0058	0.0314	CbGpPWpGaD
Rifabutin—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.00566	0.0383	CcSEcCtD
Rifabutin—HSP90B1—spinal cord—amyotrophic lateral sclerosis	0.00555	0.0396	CbGeAlD
Rifabutin—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00535	0.0362	CcSEcCtD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00481	0.026	CbGpPWpGaD
Rifabutin—HSP90B1—nervous system—amyotrophic lateral sclerosis	0.00468	0.0333	CbGeAlD
Rifabutin—HSP90AA1—medulla oblongata—amyotrophic lateral sclerosis	0.00455	0.0324	CbGeAlD
Rifabutin—HSP90B1—central nervous system—amyotrophic lateral sclerosis	0.0045	0.0321	CbGeAlD
Rifabutin—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00446	0.0302	CcSEcCtD
Rifabutin—HSP90AA1—Cellular response to heat stress—VCP—amyotrophic lateral sclerosis	0.0044	0.0238	CbGpPWpGaD
Rifabutin—HSP90B1—cerebellum—amyotrophic lateral sclerosis	0.0044	0.0314	CbGeAlD
Rifabutin—HSP90AA1—ErbB receptor signaling network—ERBB4—amyotrophic lateral sclerosis	0.00414	0.0224	CbGpPWpGaD
Rifabutin—HSP90AA1—spinal cord—amyotrophic lateral sclerosis	0.00406	0.0289	CbGeAlD
Rifabutin—HSP90B1—Binding and Uptake of Ligands by Scavenger Receptors—APOE—amyotrophic lateral sclerosis	0.00367	0.0198	CbGpPWpGaD
Rifabutin—HSP90B1—brain—amyotrophic lateral sclerosis	0.00357	0.0255	CbGeAlD
Rifabutin—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0035	0.0237	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00342	0.0232	CcSEcCtD
Rifabutin—HSP90AA1—nervous system—amyotrophic lateral sclerosis	0.00342	0.0244	CbGeAlD
Rifabutin—HSP90AA1—central nervous system—amyotrophic lateral sclerosis	0.00329	0.0235	CbGeAlD
Rifabutin—HSP90AA1—Loss of Nlp from mitotic centrosomes—TUBA4A—amyotrophic lateral sclerosis	0.00324	0.0175	CbGpPWpGaD
Rifabutin—HSP90AA1—cerebellum—amyotrophic lateral sclerosis	0.00322	0.0229	CbGeAlD
Rifabutin—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00319	0.0216	CcSEcCtD
Rifabutin—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00314	0.0213	CcSEcCtD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.0031	0.0167	CbGpPWpGaD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.0031	0.0167	CbGpPWpGaD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.0031	0.0167	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.00302	0.0163	CbGpPWpGaD
Rifabutin—HSP90AA1—LKB1 signaling events—MAPT—amyotrophic lateral sclerosis	0.00295	0.0159	CbGpPWpGaD
Rifabutin—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00292	0.0198	CcSEcCtD
Rifabutin—HSP90AA1—Centrosome maturation—TUBA4A—amyotrophic lateral sclerosis	0.00287	0.0155	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—CASP12—amyotrophic lateral sclerosis	0.00286	0.0155	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—ECE1—amyotrophic lateral sclerosis	0.00286	0.0155	CbGpPWpGaD
Rifabutin—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00283	0.0192	CcSEcCtD
Rifabutin—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00279	0.0189	CcSEcCtD
Rifabutin—HSP90AA1—Loss of Nlp from mitotic centrosomes—DCTN1—amyotrophic lateral sclerosis	0.00276	0.0149	CbGpPWpGaD
Rifabutin—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00269	0.0182	CcSEcCtD
Rifabutin—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00264	0.0179	CcSEcCtD
Rifabutin—HSP90AA1—Regulation of PLK1 Activity at G2/M Transition—TUBA4A—amyotrophic lateral sclerosis	0.00264	0.0143	CbGpPWpGaD
Rifabutin—HSP90AA1—Regulation of PLK1 Activity at G2/M Transition—OPTN—amyotrophic lateral sclerosis	0.00264	0.0143	CbGpPWpGaD
Rifabutin—HSP90AA1—brain—amyotrophic lateral sclerosis	0.00261	0.0186	CbGeAlD
Rifabutin—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00251	0.017	CcSEcCtD
Rifabutin—HSP90AA1—Class I PI3K signaling events mediated by Akt—CASP9—amyotrophic lateral sclerosis	0.00245	0.0133	CbGpPWpGaD
Rifabutin—HSP90AA1—Centrosome maturation—DCTN1—amyotrophic lateral sclerosis	0.00244	0.0132	CbGpPWpGaD
Rifabutin—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00243	0.0164	CcSEcCtD
Rifabutin—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.0023	0.0156	CcSEcCtD
Rifabutin—HSP90B1—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.00229	0.0124	CbGpPWpGaD
Rifabutin—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00229	0.0155	CcSEcCtD
Rifabutin—HSP90AA1—Regulation of PLK1 Activity at G2/M Transition—DCTN1—amyotrophic lateral sclerosis	0.00224	0.0121	CbGpPWpGaD
Rifabutin—HSP90B1—Toll-Like Receptors Cascades—ATF1—amyotrophic lateral sclerosis	0.00217	0.0117	CbGpPWpGaD
Rifabutin—HSP90AA1—NOD pathway—CASP9—amyotrophic lateral sclerosis	0.00216	0.0117	CbGpPWpGaD
Rifabutin—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00216	0.0146	CcSEcCtD
Rifabutin—HSP90B1—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.00209	0.0113	CbGpPWpGaD
Rifabutin—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00209	0.0142	CcSEcCtD
Rifabutin—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00203	0.0137	CcSEcCtD
Rifabutin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00199	0.0135	CcSEcCtD
Rifabutin—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00199	0.0135	CcSEcCtD
Rifabutin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00199	0.0135	CcSEcCtD
Rifabutin—HSP90AA1—G2/M Transition—TUBA4A—amyotrophic lateral sclerosis	0.00198	0.0107	CbGpPWpGaD
Rifabutin—HSP90AA1—G2/M Transition—OPTN—amyotrophic lateral sclerosis	0.00198	0.0107	CbGpPWpGaD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00198	0.0134	CcSEcCtD
Rifabutin—HSP90AA1—Mitotic G2-G2/M phases—OPTN—amyotrophic lateral sclerosis	0.00195	0.0106	CbGpPWpGaD
Rifabutin—HSP90AA1—Mitotic G2-G2/M phases—TUBA4A—amyotrophic lateral sclerosis	0.00195	0.0106	CbGpPWpGaD
Rifabutin—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00192	0.013	CcSEcCtD
Rifabutin—Shock—Riluzole—amyotrophic lateral sclerosis	0.00188	0.0127	CcSEcCtD
Rifabutin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00187	0.0127	CcSEcCtD
Rifabutin—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00185	0.0126	CcSEcCtD
Rifabutin—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00182	0.0123	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00174	0.0118	CcSEcCtD
Rifabutin—HSP90B1—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.00174	0.00938	CbGpPWpGaD
Rifabutin—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00173	0.0117	CcSEcCtD
Rifabutin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00171	0.0116	CcSEcCtD
Rifabutin—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.0017	0.0115	CcSEcCtD
Rifabutin—HSP90AA1—G2/M Transition—DCTN1—amyotrophic lateral sclerosis	0.00168	0.0091	CbGpPWpGaD
Rifabutin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00168	0.0114	CcSEcCtD
Rifabutin—HSP90AA1—Mitotic G2-G2/M phases—DCTN1—amyotrophic lateral sclerosis	0.00166	0.00898	CbGpPWpGaD
Rifabutin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00166	0.0112	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00165	0.0112	CcSEcCtD
Rifabutin—Pain—Riluzole—amyotrophic lateral sclerosis	0.00163	0.0111	CcSEcCtD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.0016	0.00866	CbGpPWpGaD
Rifabutin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00157	0.0107	CcSEcCtD
Rifabutin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00156	0.0106	CcSEcCtD
Rifabutin—HSP90AA1—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.00155	0.0084	CbGpPWpGaD
Rifabutin—CYP1A2—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.00152	0.0082	CbGpPWpGaD
Rifabutin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00151	0.0102	CcSEcCtD
Rifabutin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00151	0.0102	CcSEcCtD
Rifabutin—HSP90AA1—Binding and Uptake of Ligands by Scavenger Receptors—APOE—amyotrophic lateral sclerosis	0.00143	0.00774	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.00143	0.00772	CbGpPWpGaD
Rifabutin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00952	CcSEcCtD
Rifabutin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00927	CcSEcCtD
Rifabutin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00914	CcSEcCtD
Rifabutin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00884	CcSEcCtD
Rifabutin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00822	CcSEcCtD
Rifabutin—Rash—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00815	CcSEcCtD
Rifabutin—HSP90B1—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.0012	0.0065	CbGpPWpGaD
Rifabutin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00814	CcSEcCtD
Rifabutin—Headache—Riluzole—amyotrophic lateral sclerosis	0.0012	0.0081	CcSEcCtD
Rifabutin—HSP90B1—Immune System—KIFAP3—amyotrophic lateral sclerosis	0.00116	0.00625	CbGpPWpGaD
Rifabutin—HSP90AA1—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.00114	0.00615	CbGpPWpGaD
Rifabutin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00768	CcSEcCtD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—CASP9—amyotrophic lateral sclerosis	0.00113	0.00612	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—CASP9—amyotrophic lateral sclerosis	0.00113	0.00612	CbGpPWpGaD
Rifabutin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00109	0.00589	CbGpPWpGaD
Rifabutin—HSP90AA1—Hypoxic and oxygen homeostasis regulation of HIF-1-alpha—TP53—amyotrophic lateral sclerosis	0.00108	0.00584	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.00102	0.00553	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFR1 specific signals—VEGFA—amyotrophic lateral sclerosis	0.00102	0.00551	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—GSR—amyotrophic lateral sclerosis	0.000967	0.00523	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—VCP—amyotrophic lateral sclerosis	0.000934	0.00505	CbGpPWpGaD
Rifabutin—HSP90AA1—EPHA-mediated growth cone collapse—VEGFA—amyotrophic lateral sclerosis	0.000898	0.00485	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	0.000895	0.00484	CbGpPWpGaD
Rifabutin—HSP90AA1—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000877	0.00474	CbGpPWpGaD
Rifabutin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000841	0.00454	CbGpPWpGaD
Rifabutin—HSP90AA1—Integrins in angiogenesis—IGF1—amyotrophic lateral sclerosis	0.000839	0.00454	CbGpPWpGaD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000801	0.00433	CbGpPWpGaD
Rifabutin—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.0008	0.00571	CbGeAlD
Rifabutin—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00077	0.00549	CbGeAlD
Rifabutin—HSP90AA1—Axon guidance—PFN1—amyotrophic lateral sclerosis	0.000768	0.00415	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000756	0.00408	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—CASP9—amyotrophic lateral sclerosis	0.000717	0.00387	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.000705	0.00381	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—ATF1—amyotrophic lateral sclerosis	0.000701	0.00379	CbGpPWpGaD
Rifabutin—HSP90AA1—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000686	0.00371	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—DCTN1—amyotrophic lateral sclerosis	0.000682	0.00369	CbGpPWpGaD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.00068	0.00367	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—CASP9—amyotrophic lateral sclerosis	0.000668	0.00361	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—CASP9—amyotrophic lateral sclerosis	0.000659	0.00356	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.00063	0.00341	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.00063	0.00341	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—ERBB4—amyotrophic lateral sclerosis	0.000614	0.00332	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	0.000572	0.00309	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—ERBB4—amyotrophic lateral sclerosis	0.000564	0.00305	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.000564	0.00305	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.000564	0.00305	CbGpPWpGaD
Rifabutin—HSP90AA1—LKB1 signaling events—TP53—amyotrophic lateral sclerosis	0.000562	0.00304	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—TPK1—amyotrophic lateral sclerosis	0.00055	0.00297	CbGpPWpGaD
Rifabutin—HSP90AA1—Integrins in angiogenesis—VEGFA—amyotrophic lateral sclerosis	0.000548	0.00296	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000548	0.00296	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.000536	0.0029	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—amyotrophic lateral sclerosis	0.000516	0.00279	CbGpPWpGaD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—MMP9—amyotrophic lateral sclerosis	0.000509	0.00275	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.000479	0.00259	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—CASP3—amyotrophic lateral sclerosis	0.000477	0.00258	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.000477	0.00258	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—C3—amyotrophic lateral sclerosis	0.000475	0.00257	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000461	0.00249	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000461	0.00249	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—KIFAP3—amyotrophic lateral sclerosis	0.000452	0.00244	CbGpPWpGaD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—MMP9—amyotrophic lateral sclerosis	0.000443	0.0024	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—VTA1—amyotrophic lateral sclerosis	0.00044	0.00238	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—SOD1—amyotrophic lateral sclerosis	0.000437	0.00236	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000436	0.00235	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—GSTP1—amyotrophic lateral sclerosis	0.000427	0.00231	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000422	0.00228	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—ATF1—amyotrophic lateral sclerosis	0.000409	0.00221	CbGpPWpGaD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—VEGFA—amyotrophic lateral sclerosis	0.000398	0.00215	CbGpPWpGaD
Rifabutin—CYP1A2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000397	0.00215	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000392	0.00212	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CASP9—amyotrophic lateral sclerosis	0.000389	0.0021	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000368	0.00199	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—VEGFA—amyotrophic lateral sclerosis	0.000359	0.00194	CbGpPWpGaD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—TP53—amyotrophic lateral sclerosis	0.000346	0.00187	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—VEGFA—amyotrophic lateral sclerosis	0.000339	0.00183	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—TP53—amyotrophic lateral sclerosis	0.000335	0.00181	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000333	0.0018	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000333	0.0018	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—ERBB4—amyotrophic lateral sclerosis	0.000333	0.0018	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.000319	0.00173	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000313	0.00169	CbGpPWpGaD
Rifabutin—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000312	0.00169	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PLB1—amyotrophic lateral sclerosis	0.000302	0.00163	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000283	0.00153	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—C3—amyotrophic lateral sclerosis	0.000277	0.0015	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—ATF1—amyotrophic lateral sclerosis	0.000274	0.00148	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—VCP—amyotrophic lateral sclerosis	0.000269	0.00145	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—DCTN1—amyotrophic lateral sclerosis	0.000266	0.00144	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CASP9—amyotrophic lateral sclerosis	0.000261	0.00141	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000253	0.00136	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000233	0.00126	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	0.000223	0.00121	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000218	0.00118	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000218	0.00118	CbGpPWpGaD
Rifabutin—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.000216	0.00117	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000211	0.00114	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000199	0.00108	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000199	0.00107	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CST3—amyotrophic lateral sclerosis	0.000193	0.00104	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000191	0.00103	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	0.000188	0.00102	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000188	0.00102	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—C3—amyotrophic lateral sclerosis	0.000185	0.001	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000185	0.001	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000182	0.000985	CbGpPWpGaD
Rifabutin—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000176	0.000952	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—VEGFA—amyotrophic lateral sclerosis	0.000174	0.000941	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000174	0.00094	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.00017	0.000919	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—MMP9—amyotrophic lateral sclerosis	0.000165	0.00089	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000162	0.000875	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.00016	0.000865	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ATF1—amyotrophic lateral sclerosis	0.00016	0.000862	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CASP9—amyotrophic lateral sclerosis	0.000152	0.000821	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.000148	0.000801	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—VEGFA—amyotrophic lateral sclerosis	0.000148	0.000799	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CASP9—amyotrophic lateral sclerosis	0.00014	0.000758	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—TP53—amyotrophic lateral sclerosis	0.000132	0.000711	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ERBB4—amyotrophic lateral sclerosis	0.00013	0.000703	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000127	0.000684	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000125	0.000674	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000122	0.000661	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—ERBB4—amyotrophic lateral sclerosis	0.00012	0.000649	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000119	0.000645	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MMP9—amyotrophic lateral sclerosis	0.000118	0.000635	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.00011	0.000594	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—C3—amyotrophic lateral sclerosis	0.000108	0.000584	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	0.000106	0.00057	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000103	0.000557	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000103	0.000556	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.82e-05	0.000531	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.76e-05	0.000528	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	9.69e-05	0.000524	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	9.69e-05	0.000524	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	9.63e-05	0.00052	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.45e-05	0.000511	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—APOE—amyotrophic lateral sclerosis	9.29e-05	0.000502	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9.04e-05	0.000488	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	8.87e-05	0.000479	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.41e-05	0.000454	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.24e-05	0.000445	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.9e-05	0.000427	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—APOE—amyotrophic lateral sclerosis	7.78e-05	0.00042	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	7.75e-05	0.000419	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	7.48e-05	0.000404	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	7.48e-05	0.000404	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—TP53—amyotrophic lateral sclerosis	7.38e-05	0.000399	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	7.01e-05	0.000379	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.99e-05	0.000377	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	6.84e-05	0.00037	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.5e-05	0.000351	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTGS2—amyotrophic lateral sclerosis	6.36e-05	0.000344	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.36e-05	0.000344	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	5.98e-05	0.000323	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	5.41e-05	0.000292	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.37e-05	0.00029	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.33e-05	0.000288	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	5.31e-05	0.000287	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	4.9e-05	0.000265	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.46e-05	0.000241	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.14e-05	0.000224	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	4.1e-05	0.000222	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	4.03e-05	0.000218	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.91e-05	0.000211	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	3.78e-05	0.000204	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.67e-05	0.000198	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.51e-05	0.00019	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	3.11e-05	0.000168	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.65e-05	0.000143	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.52e-05	0.000136	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.16e-05	0.000117	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.99e-05	0.000107	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.67e-05	9.02e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.64e-05	8.84e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.53e-05	8.29e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.26e-05	6.82e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.12e-05	6.06e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.65e-06	4.67e-05	CbGpPWpGaD
